Amcor plc (AMCR) Q3 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary presents a mixed outlook. Positive aspects include reaffirmed EPS and cash flow guidance, significant synergy achievements, and increased segment sales due to acquisitions. However, concerns arise from declining volumes, inflation volatility, and management's unclear responses on key issues like inflation and volume trends. The Q&A session reveals uncertainties in cash flow and market share gains. Overall, the positive and negative factors balance out, resulting in a neutral sentiment.
Key Financial Performance
Adjusted EPS (Earnings Per Share) $0.96 per share for Q3, up 6% year-over-year. Reasons for the increase include benefits from tax-related synergies and disciplined cost management, partially offset by a $25 million unfavorable impact from winter storms in the U.S.
Adjusted EPS (First 9 months) $2.79 per share, up 11% year-over-year. Growth driven by synergies, cost and productivity improvements, and responsible pricing actions.
Revenue $5.9 billion for Q3, significantly higher than the prior year due to the Berry acquisition, disciplined cost management, improved productivity, and accelerating synergy benefits.
EBITDA $892 million for Q3, significantly higher than the prior year, driven by the Berry acquisition and synergy benefits.
EBIT $687 million for Q3, significantly higher than the prior year, attributed to the Berry acquisition and disciplined cost management.
Synergies $77 million delivered in Q3 and $170 million for the first 9 months. Expected to reach $270 million for fiscal 2026, exceeding the initial $260 million target. Synergies include G&A, procurement, and financial optimizations.
Free Cash Flow Outflow of $39 million for Q3 after funding $78 million of Berry transaction-related costs. Year-to-date outflow of $93 million. Fiscal 2026 free cash flow expected to be $1.5 billion to $1.6 billion, revised down due to higher inventory levels.
Dividend $0.65 per share for Q3, modestly up over the prior year, aligned with the company's capital allocation framework.
Global Flexible Packaging Solutions Segment Sales Increased 29% on a constant currency basis for Q3, driven by the Berry acquisition. Comparable volumes down approximately 1.5%, with mid-single-digit growth in Asia.
Global Rigid Packaging Solutions Segment Sales Increased significantly on a constant currency basis for Q3, mainly due to the Berry acquisition. Comparable volumes down approximately 1.5%, with mid-single-digit growth in Latin America.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Portfolio Optimization: Amcor has closed or reached agreements for the divestiture of 6 noncore businesses, representing approximately $500 million of combined annual revenue. The proceeds will be used to reduce debt, sharpening focus on higher return and growth opportunities in the $20 billion core portfolio.
Core Portfolio Performance: The $20 billion core portfolio includes 6 focus categories: healthcare, beauty and wellness, proteins, liquids, foodservice, and pet care. These categories represent 50% of core portfolio sales and continue to outperform the total company with stronger EBIT margins of 12.3%.
Synergy Realization: Amcor achieved $77 million in synergies in Q3 and $170 million for the first 9 months of fiscal 2026. The company expects to exceed its initial year 1 target of $260 million, reaching $270 million in synergies for fiscal 2026.
Financial Performance: Amcor reported Q3 revenue of $5.9 billion, EBITDA of $892 million, and EBIT of $687 million. Adjusted EPS increased 6% year-over-year to $0.96 per share, with a 12% growth expected for fiscal 2026.
Free Cash Flow: Free cash flow is expected to be in the range of $1.5 billion to $1.6 billion for fiscal 2026, impacted by higher inventory costs due to supply chain adjustments.
Berry Acquisition Integration: Amcor has successfully integrated Berry, achieving synergy benefits and identifying additional opportunities for growth. The acquisition has strengthened Amcor's global portfolio and operational capabilities.
Fiscal Year-End Transition: Amcor will transition its fiscal year-end to December 31 starting in 2027, enhancing comparability with peers and simplifying financial modeling.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Middle East Conflict: Potential supply chain disruptions and cost inflation due to the Middle East conflict. The company has taken measures to mitigate these risks, but the situation remains a challenge.
Input Cost Inflation: Significant inflation in input costs exceeding historical norms, requiring swift pricing and cost management actions to maintain earnings.
Working Capital Management: Decisions to hold higher inventory levels to ensure supply continuity have impacted the timing of working capital improvements and free cash flow.
Winter Storm Impact: Unfavorable $25 million impact from U.S. winter storms, causing lost production days and affecting EBIT margins.
Noncore Business Divestitures: Ongoing divestitures of noncore businesses, while improving focus, may pose risks related to execution and financial performance during the transition.
Leverage and Debt Management: Adjusted leverage remains high at 3.8x, with a commitment to reduce it to 2.5-3x, posing risks if free cash flow generation does not meet expectations.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Adjusted EPS for Fiscal Year 2026: Expected to be in the range of $3.98 to $4.03 per share, representing approximately 12% growth at the midpoint.
Fourth Quarter Adjusted EPS Growth: Projected to grow by approximately 20% year-over-year.
Synergy Realization: Expected to deliver $270 million in fiscal 2026, exceeding the initial $260 million target, with cumulative synergies of $650 million over three years.
Free Cash Flow for Fiscal 2026: Revised to $1.5 billion to $1.6 billion, down from the original $1.8 billion to $1.9 billion, due to higher inventory costs and timing impacts.
Year-End Leverage: Expected to be approximately 3.4 to 3.5x, with a long-term target of 2.5 to 3x.
Core Portfolio Performance: Focus categories expected to drive stronger EBIT margins and growth, with continued investment in healthcare, beauty and wellness, proteins, liquids, foodservice, and pet care.
Noncore Business Divestitures: Six divestitures completed or agreed upon, generating $500 million in transaction value, with proceeds allocated to debt reduction.
Capital Spending for Fiscal 2026: Projected to be in the range of $850 million to $900 million.
Transition to Calendar Fiscal Year: Effective January 1, 2027, with a six-month transition period from July 1, 2026, to December 31, 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividend: The Board declared a quarterly dividend of $0.65 per share, which is modestly up over the prior year and aligned with the company's capital allocation framework and long-term commitment to annualized dividend growth.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the impact of the Middle East crisis on the company's operations and inflation management?
A:The company has minimal exposure to the Middle East, sourcing less than 5% of resin from the region. Management is focused on securing supply and offsetting inflation through structured processes and collaborative customer approaches. They have mechanisms in place to pass through costs, with 70% of business under contracts and 30% managed through general price increases. However, the inflation outlook remains volatile and uncertain.
Q:Will the company's free cash flow be impacted in the quarters following the June quarter of 2026 due to higher inventories?
A:The CFO stated that the Q4 impact on cash flow is due to inflation on inventory. Beyond Q4, the cash flow implications depend on market stabilization and supply chain normalization. It is unpredictable whether cash flow headwinds will persist.
Q:How is the consumer environment affecting the company's performance?
A:The company reported a 1.5% decline in Q3 volumes, with improvements in non-core business and emerging markets. Management noted that consumers are stretched due to inflation, but large customers are performing well and committed to supporting volumes. The company expects the market to be down low single digits in the second half of the calendar year.
Q:Has the company gained market share due to its global presence and product availability?
A:The company is well-positioned in terms of supply due to its global procurement network and minimal reliance on the Middle East. While there have been some customer inquiries for additional support, it is too early to determine significant market share gains.
Q:What is the company's plan for reducing leverage over the next 12 months?
A:The company aims to reduce leverage to 3x or below by fiscal and calendar 2027 through divestitures, synergy capture, and cash flow management. The current leverage guidance for year-end is 3.4 to 3.5x, with expectations for improvement in the next fiscal year.
Q:What is the outlook for volumes in Q4 and beyond?
A:Management expects Q4 volumes to be similar to Q3, with no significant changes anticipated. April volumes looked better than expected, but it is unclear if this is due to pre-buying or other factors. Promotional activities by large customers may support volumes.
Q:How is the company managing the impact of resin price increases?
A:The company is addressing resin price increases through collaborative customer discussions and leveraging its inventory to mitigate abrupt cost changes. Contracts with opening clauses and a structured approach to pricing adjustments are being utilized.
Q:What is the progress on synergy targets and growth synergies?
A:The company has achieved $270 million in year 1 synergies, exceeding expectations, and is on track for $260 million in year 2. Growth synergies have reached $100 million annualized, driven by complementary product portfolios and global capabilities.
Q:Has the composition of the non-core portfolio changed, and how is the divestiture process progressing?
A:The non-core portfolio composition has not changed. The company is making progress on divestitures, with improved performance in the North American beverage business and ongoing discussions for other assets. The Middle East crisis has not impacted the divestiture timeline.
Q:What is the performance of the healthcare and nutrition categories?
A:Healthcare volumes were slightly down due to winter storms and a weaker cold and flu season, but the category remains strong with positive mix and new customer wins. Nutrition saw weakness in discretionary categories like confectioneries and fresh/frozen food, but focus categories within nutrition performed well.
Q:What is the company's leverage outlook for the stub period and fiscal 2027?
A:Leverage is expected to remain stable during the stub period and improve significantly in fiscal and calendar 2027 due to synergy capture, divestitures, and cash flow recovery. The company is committed to maintaining an investment-grade rating.
Q:Review of Unclear Management Responses
A:Management avoided providing a clear answer on the specific inflation outlook for the back half of the year, citing volatility and uncertainty. They also did not provide detailed reasons for better-than-expected April volumes, leaving it unclear if pre-buying or other factors were at play.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
East conflict
Middle East
Sales segment
Slide PK
agreement
allocation priority
capital allocation
capital improvement
cash proceeds
concentration
condition
conflict supply
continuity
core portfolio
cost inflation
cost pricing
divestiture basis
dividend
dollar
end expectation
healthcare nutrition
integration cash
inventory
net divestiture
noncore business
nutrition EBIT
outflow
quality resilience
restructuring integration
synergy month
tax
transaction restructuring
transaction value
winter storm
AMCR Transcript
Amcor plc (AMCR) Q3 2026 Earnings Call Transcript
Unknown5-6
The earnings call summary presents a mixed outlook. Positive aspects include reaffirmed EPS and cash flow guidance, significant synergy achievements, and increased segment sales due to acquisitions. However, concerns arise from declining volumes, inflation volatility, and management's unclear responses on key issues like inflation and volume trends. The Q&A session reveals uncertainties in cash flow and market share gains. Overall, the positive and negative factors balance out, resulting in a neutral sentiment.
Amcor plc (AMCR) Q2 2026 Earnings Call Transcript
Positive2-3
The earnings call highlights strong financial performance, with significant EBIT growth and increased dividends. The strategic focus on synergy realization and core portfolio optimization is promising, despite a slight volume decline. The Q&A reveals a consistent market outlook and potential EBIT improvements, with management addressing concerns effectively. The announcement of increased dividends and strong cash flow further supports a positive sentiment, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
Amcor plc (AMCR) Q1 2026 Earnings Call Transcript
Unknown11-6
The earnings call presents mixed signals: positive EBIT growth, margin improvements, and synergies suggest strong financial health. However, challenges like volume declines, particularly in Europe, and lack of clarity on divestment timelines pose concerns. The Q&A reveals management's cautious approach and uncertainties in certain sectors. Despite strong EPS growth projections, flat volume expectations and market softness in key areas temper optimism. Without a market cap, the impact on stock price is uncertain, leading to a neutral prediction.
Amcor plc (AMCR) Q4 2025 Earnings Call Transcript
Positive8-14
The earnings call highlights strong financial performance, with significant revenue growth driven by the Berry acquisition and favorable synergies. Despite challenges in the North American beverage business, the company maintains a positive outlook with clear strategies for improvement. The focus on deleveraging and potential future share buybacks is a positive signal. The Q&A section did not reveal any major negative trends or risks, and the synergy targets are on track. Overall, the positive elements outweigh the concerns, suggesting a positive stock price movement in the near term.
AMCR Slides
AMCR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
